Some have given up hope after several Months of waiting for their disbursement even when it is very clear their loans have been approved. We are here to say, never give up hope on anything because there is always a way to get around everything with patience.
If your loan has been approved but the disbursement is pending, here are 4 options which will communicate your issues to Nirsal Microfinance Bank for direct resolution.
The Nirsal Microfinance Bank Email Address: An e-mail address has been provided by the bank to enable applicants having issues tender their complaints.
All you have to do is to detail your problem/issue to [email protected] and wait for a reply from the bank. When writing your complaints, ensure to include your loan application details such Phone Number, Full Names and BVN used during application.
If you had supplied Account details after accepting the offer, include the account details.
2. Nirsal Microfinance Bank Twitter Handle: Twitter has become the most effective way of contacting the Government or its agencies and NMFB has recently been very active on their Social handles including Twitter.
Your issues can be solved by sending a Direct Message, detailing your issues through the official handle mobile.twitter.com/NirsalMFB.
When Twitter handle opens, locate the Message Icon below the Profile Pics. Click on it and type in your complaint, and send as a direct message. Ensure to include your essential details as in No 1.
Note that while these Methods have become the most effective ways of contacting the Nirsal Microfinance Bank, due to the volume of complaint recieved on daily bases, there would be a waiting time. So be patient.
If you need us to help you with more updated information about Covid-19 Loan, kindly feel free to ask any question in the comment box below. You can also provide us your phone number or email Address for more updates.
Please, kindly use the Facebook, Twitter, Google+ and WhatsApp share buttons below to help others, thanks.
Wazobia Info Nigeria
Always Serving You Better.